Sarcolemmal and mitochondrial effects of a KATP opener, P-1075, in "polarized" and "depolarized" Langendorff-perfused rat hearts

Biochim Biophys Acta. 2003 Dec 3;1618(1):39-50. doi: 10.1016/j.bbamem.2003.10.004.

Abstract

We investigated consequences of cardiac arrest on sarcolemmal and mitochondrial effects of ATP-sensitive potassium channel (KATP) opener, P-1075, in Langendorff-perfused rat hearts. Depolarised cardiac arrest (24.7 mM KCl) did not affect glibenclamide-sensitive twofold activation of rubidium efflux by P-1075 (5 microM) from rubidium-loaded hearts, but eliminated uncoupling produced by P-1075 in beating hearts: 40% depletion of phosphocreatine and ATP, 50% increase in oxygen consumption, and reduction of cytochrome c oxidase. Depolarized cardiac arrest by calcium channel blocker, verapamil (5 microM), also prevented uncoupling. Lack of P-1075 mitochondrial effects in depolarized hearts was not due to changes in phosphorylation potential, because 2,4-dintrophenol (10 microM) reversed the [PCr]/[Cr] increase and Pi decrease, characteristic of KCl-arrest, but did not restore uncoupling. In agreement with this conclusion, pyruvate (5 mM) increased [PCr]/[Cr] and decreased Pi, but did not prevent uncoupling in beating hearts. A decrease in mean [Ca2+] in KCl-arrested hearts could not account for lack of P-1075 mitochondrial effects, because calcium channel opener, S-(-)-Bay K8644 (50 nM), and beta-agonist, isoproterenol (0.5 microM), did not facilitate uncoupling. In contrast, in adenosine (1 mM)-arrested hearts (polarized arrest), P-1075 caused 40% phosphocreatine and ATP depletion. In isolated rat liver mitochondria, P-1075 (20 microM) decreased mitochondrial membrane potential (DeltaPsi) by approximately 14 mV (demonstrated by redistribution of DeltaPsi-sensitive dye, rhodamine 800) in a glibenclamide-sensitive manner. We concluded that cell membrane depolarization does not prevent activation of sarcolemmal KATP by P-1075, but it plays a role in mitochondrial uncoupling effects of P-1075.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Guanidines / pharmacology*
  • Heart / drug effects*
  • Heart Arrest, Induced
  • Liver / metabolism
  • Male
  • Membrane Potentials
  • Mitochondria / drug effects*
  • Potassium / metabolism
  • Pyridines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Rubidium / metabolism
  • Sarcolemma / drug effects*
  • Vasodilator Agents / pharmacology*

Substances

  • Guanidines
  • Pyridines
  • Vasodilator Agents
  • N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine
  • Rubidium
  • Potassium